12:00 AM
 | 
Mar 12, 2007
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Calistoga Pharmaceuticals Inc.

Seattle, Wash.

Technology: Specific inhibitors of p110, a catalytic subunit of

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >